Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Related Citations for PubMed (Select 22325464)

1.

PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy.

Holmqvist A, Gao J, Holmlund B, Adell G, Carstensen J, Langford D, Sun XF.

BMC Cancer. 2012 Feb 10;12:65. doi: 10.1186/1471-2407-12-65.

2.

PINCH expression in relation to radiation response in co-cultured colon cancer cells and in rectal cancer patients.

Holmqvist A, Holmlund B, Ardsby M, Pathak S, Sun XF.

Oncol Rep. 2013 Nov;30(5):2097-104. doi: 10.3892/or.2013.2673. Epub 2013 Aug 20.

PMID:
23970013
3.

Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.

Loftås P, Onnesjö S, Widegren E, Adell G, Kayed H, Kleeff J, Zentgraf H, Sun XF.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):137-42. doi: 10.1016/j.ijrobp.2008.10.076. Epub 2009 Mar 14.

PMID:
19289258
4.

Impact of PINCH expression on survival in colorectal cancer patients.

Lööf J, Rosell J, Bratthäll C, Doré S, Starkhammar H, Zhang H, Sun XF.

BMC Cancer. 2011 Mar 22;11:103. doi: 10.1186/1471-2407-11-103.

5.

The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy.

Holmqvist A, Gao J, Adell G, Carstensen J, Sun XF.

Ann Oncol. 2010 Mar;21(3):512-7. doi: 10.1093/annonc/mdp486. Epub 2009 Nov 4.

6.

AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.

Gnosa S, Zhang H, Brodin VP, Carstensen J, Adell G, Sun XF.

Br J Cancer. 2014 Jul 8;111(1):166-73. doi: 10.1038/bjc.2014.250. Epub 2014 May 29.

7.

Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy.

Ding ZY, Zhang H, Adell G, Olsson B, Sun XF.

Radiat Oncol. 2013 Dec 2;8:281. doi: 10.1186/1748-717X-8-281.

8.

Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.

Yao YF, Du CZ, Chen N, Chen P, Gu J.

Dis Colon Rectum. 2014 May;57(5):602-7. doi: 10.1097/DCR.0000000000000107.

PMID:
24819100
9.
10.

Gender-related differences in pathological and clinical tumor response based on immunohistochemical proteins expression in rectal cancer patients treated with short course of preoperative radiotherapy.

Gasinska A, Adamczyk A, Niemiec J, Biesaga B, Darasz Z, Skolyszewski J.

J Gastrointest Surg. 2014 Jul;18(7):1306-18. doi: 10.1007/s11605-014-2526-0. Epub 2014 Apr 23.

PMID:
24756926
11.

PINCH expression and its clinicopathological significance in gastric adenocarcinoma.

Zhu ZL, Yan BY, Zhang Y, Yang YH, Wang ZM, Zhang HZ, Wang MW, Zhang XH, Sun XF.

Dis Markers. 2012;33(4):171-8. doi: 10.3233/DMA-2012-0930.

12.
13.

Particularly interesting new cysteine-histidine rich protein expression in colorectal adenocarcinomas.

Zhao ZR, Zhang ZY, Cui DS, Jiang L, Zhang HJ, Wang MW, Sun XF.

World J Gastroenterol. 2006 Jan 14;12(2):298-301.

14.

pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.

Moparthi SB, Bergman V, Adell G, Thorstensson S, Sun XF.

Int J Colorectal Dis. 2009 Nov;24(11):1303-10. doi: 10.1007/s00384-009-0767-2. Epub 2009 Jul 14.

PMID:
19597825
15.

Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer.

Gao J, Arbman G, Rearden A, Sun XF.

Neoplasia. 2004 Nov-Dec;6(6):796-801.

16.

Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.

Gaber A, Stene C, Hotakainen K, Nodin B, Palmquist I, Bjartell A, Stenman UH, Jeppsson B, Johnson LB, Jirström K.

Radiat Oncol. 2011 Aug 24;6:100. doi: 10.1186/1748-717X-6-100.

17.

SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.

Kotti A, Holmqvist A, Albertsson M, Sun XF.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1196-202. doi: 10.1016/j.ijrobp.2013.12.041.

PMID:
24661672
18.

Expression of MAC30 in rectal cancers with or without preoperative radiotherapy.

Zhang ZY, Zhao ZR, Adell G, Jarlsfelt I, Cui YX, Kayed H, Kleeff J, Wang MW, Sun XF.

Oncology. 2006;71(3-4):259-65. Epub 2007 Jul 26.

PMID:
17657172
19.

Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.

Wallin AR, Svanvik J, Adell G, Sun XF.

Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):452-8. Epub 2006 Apr 19.

PMID:
16626893
20.

Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.

Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, Dorval E, de Calan L, Huten N, le Folch O, Calais G.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):619-27.

PMID:
9112461
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk